"We
have been providing companies and trade associations worldwide with
unparalleled service for over 20 years, and currently have clients and
projects in 120 countries across six continents."TO SEE THE STAFF LISTED BY BUSINESS AREA USE THE LINKS BELOW:
Our Agri, Biotech & Consumer Products Team
The Agri, Biotech and Consumer Products Group is a diversified team of scientists providing expert advice in their fields. Clients can be assured whichever team member they may deal with will provide them with superior counsel, which leads to our high rate of repeat business. Please learn more about our team by selecting a bio from the list below of our key contacts. We have only listed senior staff on the website, additional members of the team have bios that are available upon request.
Principals
Senior Scientific & Regulatory Consultants
Scientific & Regulatory Consultants
- Jeffrey Card, Ph.D., Scientific & Regulatory Consultant
- Wendy Pearson, Ph.D., Scientific & Regulatory Consultant
Barry S. Lynch, B.Sc., DABT
Associate Director
As a Senior Scientist, Mr. Lynch has been involved primarily in the Health Sciences section, specializing in pharmaceutical and food toxicology/ regulatory affairs. With his expertise and strong scientific background he supports clients in general toxicology, mechanisms of toxicity, metabolism, and the pathobiology of chemical carcinogenesis in laboratory animals.
Since joining Cantox in 1989, Mr. Lynch serves extensively as a senior scientific advisor and resource person for projects involving complex toxicological issues, preparing countless technical reports for submission to regulatory authorities, on behalf of clients in the food, pharmaceutical, chemical manufacturing, biotechnology, and pesticide industries. These reports involve the detailed assessment of toxicology, carcinogenicity, mechanistic, metabolism, phamacokinetic/pharmacodynamic and other data addressing specific regulatory concerns or as part of comprehensive safety evaluations. Included, is the preparation of the toxicology portions of generally recognized as safe (GRAS) dossiers. With a strong chemistry background, he has been responsible for the assessment of technical data prepared for submission to Environment Canada under the NSN Regulations (CEPA). As part of these responsibilities, Mr. Lynch works with CEPA team members to develop testing and regulatory strategies for products requiring assessment under the NSN Regulations.
Mr. Lynch has authored over 30 scientific publications/abstracts, numerous toxicological monographs, and hundreds of confidential technical reports. His reports have been submitted to international authorities including the US FDA, US EPA, the Canadian HPB, EFSA, JECFA and the Japanese Ministry of Health and Welfare.
Mr. Lynch graduated from York University with an honours B.Sc. in Biochemistry and Toxicology. In 2001, he was certified as a Diplomate of the American Board of Toxicology (DABT) was accepted in 2005 on the UK Register of Toxicologists and becoming a Eurotox Registered Toxicologist. Mr. Lynch is also a member of the Society of Toxicology and of the Society of Toxicologic Pathologists.
Jeffrey Card, Ph.D.
Scientific & Regulatory Consultant
Dr. Card is a Scientist who utilizes his expertise in toxicology to address complex safety, risk assessment, study design, and regulatory issues. He has managed and contributed to the successful completion of a variety of projects for clients in the food, biotech, pharmaceutical, and chemical industries including generally recognized as safe (GRAS) assessments, risk assessments, determination of excipient and drug contaminant issues, and evaluations of air quality standards. Dr. Card is also the head of the Cantox nanotechnology team, serving as a vital resource and manager of projects related to nanotechnology and nanotoxicology.
After receiving his Ph.D. in Pharmacology and Toxicology from Queen’s University,
Dr. Card spent
4 years as a postdoctoral fellow at the National Institute of Environmental
Health Sciences in Research Triangle Park, where he studied the regulatory roles of
eicosanoids and sex hormones in lung physiology and disease. He has over 10 years of research
experience in academic and government laboratories, has authored nearly 20
peer-reviewed articles in the fields of toxicology, physiology, and
carcinogenesis, and has given presentations at local, national, and
international scientific meetings. His academic and research excellence have been
recognized in the form of travel, scholarship, and fellowship awards from the
Davies Charitable Foundation, the Canadian Institutes of Health Research,
the Society of Toxicology, the American Lung Association of North Carolina,
and the National Institutes of Health. Dr. Card is currently a member of the Society
of Toxicology of Canada, the Society of Toxicology, and the American
Association for the Advancement of Science.
Wendy Pearson,
Ph.D.
Scientific & Regulatory Consultant
CanTox Health Sciences International introduces a new business area in nutraceuticals for animals. Wendy Pearson has joined CanTox and will focus on R & D services for the rapidly growing animal nutraceuticals sector. With a Masters degree in Nutritional Toxicology and a PhD in Biomedical Toxicology, Wendy has more than 10 years experience with experimental research on herbs, nutraceuticals, functional foods and clinical nutrition of livestock species, with particular expertise in horses.
Founder and President of Nutraceutical Alliance Inc. for 6 years, Wendy has successfully matched industry with government sources of research funding, as well as developed innovative scientific strategies for showing safety and efficacy of nutraceuticals in animals. CanTox services within this new business area include:
- product development strategies for nutraceuticals in livestock and companion animals;
- R & D program planning and management;
- design, implementation and critical evaluation of:
- efficacy studies (eg. in vitro and in vivo models of arthritis, respiratory disease, immune dysfunction, gastrointestinal diseases,growth promotion etc.,
in target species); - workshops and seminars on nutraceuticals for animals;
- risk assessment of individual constituents, including secondary risk to humans from nutraceutical-consuming food animals; and
- facilitation of client access to external research funding.
- toxicity studies (eg. acute and repeated-dose toxicity, safety, pharmacology, genotoxicity, reproductive toxicity) and pharmacokinetic studies (ADME);